(2023). Evaluation of disease progression and response to therapy in a cohort of late childhood/adulthood SMA patients: Is there room for new markers?.

Evaluation of disease progression and response to therapy in a cohort of late childhood/adulthood SMA patients: Is there room for new markers?

LUPICA, Antonino
2023-12-01

1-dic-2023
SMA; Neurphysiology; biomarkers
(2023). Evaluation of disease progression and response to therapy in a cohort of late childhood/adulthood SMA patients: Is there room for new markers?.
File in questo prodotto:
File Dimensione Formato  
TESI PHD ANTONINO LUPICA d.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 847.78 kB
Formato Adobe PDF
847.78 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/618213
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact